# Safety and Efficacy Study of Combination Treatment With Excimer Laser, Clobex Spray, and Vectical Ointment in the Treatment of Psoriasis

> **NCT01012713** · PHASE4 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 30 (actual)

## Conditions studied

- Chronic Stable Plaque Psoriasis

## Interventions

- **DRUG:** Clobex Spray
- **DRUG:** Vectical Ointment
- **PROCEDURE:** Excimer Laser

## Key facts

- **NCT ID:** NCT01012713
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2015-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01012713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01012713, "Safety and Efficacy Study of Combination Treatment With Excimer Laser, Clobex Spray, and Vectical Ointment in the Treatment of Psoriasis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01012713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*